Transdermal Biotechnology, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
1
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Systems and methods for treating vitiligo (US 10,314,800) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 1 fee due Jan 2, 2027The maintenance fee for Methods and systems for delivery of ZW1 heptapeptide (US 10,335,450) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 2 fees due Jun 1 to 8, 2027 · next Jun 1
- 1 fee due Jul 26, 2027The maintenance fee for Topical systems and methods for treating sexual dysfunction (US 9,241,899) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.
- 2 fees due Sep 29, 2027
- 2 fees due Oct 19, 2027
- 1 fee due Nov 14, 2027The maintenance fee for Systems and methods for treatment of hearing using dihexa (US 11,980,651) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,435,942 | Methods for formulating stabilized insulin compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 9,517,179 | Topical nitric oxide systems and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,937,202 | Topical nitric oxide systems and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,668,937 | Topical nitric oxide systems and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,198,930 | Treatment of skin and soft tissue infection with nitric oxide In force · From the USPTO record | In force | From the USPTO record | |
| US 9,205,043 | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,844,565 | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 10,034,898 | Methods and systems for treatment of inflammatory diseases with nitric oxide In force · From the USPTO record | In force | From the USPTO record | |
| US 9,597,401 | Systems and methods for delivery of peptides In force · From the USPTO record | In force | From the USPTO record | |
| US 9,636,291 | Hair treatment systems and methods using peptides and other compositions In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 29: 74 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 17 no status recorded